Goldman Sachs Group »

Avita Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $741k 94k 7.92
2024-03-31 $1.3M 81k 16.03
2023-12-31 $381k 28k 13.72
2023-09-30 $329k 23k 14.61
2023-06-30 $556k 33k 17.01
2023-03-31 $1.1M 77k 13.97
2022-06-30 $87k 18k 4.76
2022-03-31 $213k 25k 8.51
2021-12-31 $978k 82k 11.98
2021-09-30 $185k 11k 17.68
2021-03-31 $2.0M 99k 19.82